• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使噬菌体适应新宿主的方案的数学比较

Mathematical comparison of protocols for adapting a bacteriophage to a new host.

作者信息

Bull James J, Krone Stephen M

机构信息

Department of Biological Sciences, University of Idaho, 875 Perimeter drive, Moscow, ID 83844, United States.

Institute for Modeling Collaboration and Innovation, University of Idaho, 875 Perimeter drive, Moscow, ID 83844, United States.

出版信息

Virus Evol. 2024 Nov 22;10(1):veae100. doi: 10.1093/ve/veae100. eCollection 2024.

DOI:10.1093/ve/veae100
PMID:39717707
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11665826/
Abstract

Interest in phage therapy-the use of bacterial viruses to treat infections-has increased recently because of the rise of infections with antibiotic-resistant bacteria and the failure to develop new antibiotics to treat those infections. Phages have shown therapeutic promise in recent work, and successful treatment minimally requires giving the patient a phage that will grow on their infecting bacterium. Although nature offers a bountiful and diverse supply of phages, there have been a surprising number of patient infections that could not be treated with phages because no suitable phage was found to kill the patient's bacterium. Here, we develop computational models to analyze an alternative approach to obtaining phages with new host ranges-directed evolution via laboratory propagation of phages to select mutants that can grow on a new host. The models separately explore alternative directed evolution protocols for phage variants that overcome three types of bacterial blocks to phage growth: a block in adsorption, temperate phage immunity to superinfection, and abortive infection. Protocols assume serial transfer to amplify pre-existing, small-effect mutants that are initially rare. Best protocols are sensitive to the nature of the block, and the models provide several insights for enhancing success specific to each case. A common result is that low dilution rates between transfers are beneficial in reducing the mutant growth rate needed to ascend. Selection to overcome an adsorption block is insensitive to many protocol variations but benefits from long selection times between transfers. A temperate phage selected to grow on its lysogens can evolve in any of three phenotypes, but a common protocol favors the desired changes in all three. Abortive infection appears to be the least amenable to evolving phage growth because it is prone to select phages that avoid infection.

摘要

由于抗生素耐药性细菌感染的增加以及未能开发出新的抗生素来治疗这些感染,人们对噬菌体疗法(利用细菌病毒治疗感染)的兴趣最近有所上升。噬菌体在最近的研究中显示出治疗前景,而成功治疗至少需要给患者使用一种能在其感染细菌上生长的噬菌体。尽管自然界提供了丰富多样的噬菌体,但令人惊讶的是,有相当数量的患者感染无法用噬菌体治疗,因为没有找到合适的噬菌体来杀死患者的细菌。在这里,我们开发了计算模型,以分析一种获得具有新宿主范围噬菌体的替代方法——通过噬菌体的实验室传代进行定向进化,以选择能够在新宿主上生长的突变体。这些模型分别探索了针对噬菌体变体的替代定向进化方案,这些变体克服了三种噬菌体生长的细菌障碍:吸附障碍、温和噬菌体对超感染的免疫以及流产感染。方案假设进行连续传代以扩增最初罕见的、具有小效应的预先存在的突变体。最佳方案对障碍的性质敏感,并且这些模型为增强每种情况的成功率提供了一些见解。一个常见的结果是,传代之间的低稀释率有利于降低上升所需的突变体生长速率。克服吸附障碍的选择对许多方案变化不敏感,但受益于传代之间的长时间选择。选择在其溶原菌上生长的温和噬菌体可以进化出三种表型中的任何一种,但一个常见的方案有利于所有三种表型发生期望的变化。流产感染似乎最不容易使噬菌体生长进化,因为它容易选择避免感染的噬菌体。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06a3/11665826/6765d952daa1/veae100f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06a3/11665826/1f42807ed9fa/veae100f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06a3/11665826/b6b20db442ab/veae100f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06a3/11665826/da69063cdfc1/veae100f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06a3/11665826/b8940f87a83f/veae100f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06a3/11665826/ca4fc724b431/veae100f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06a3/11665826/1365494b6390/veae100f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06a3/11665826/e0d180f9e075/veae100f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06a3/11665826/6765d952daa1/veae100f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06a3/11665826/1f42807ed9fa/veae100f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06a3/11665826/b6b20db442ab/veae100f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06a3/11665826/da69063cdfc1/veae100f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06a3/11665826/b8940f87a83f/veae100f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06a3/11665826/ca4fc724b431/veae100f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06a3/11665826/1365494b6390/veae100f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06a3/11665826/e0d180f9e075/veae100f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06a3/11665826/6765d952daa1/veae100f8.jpg

相似文献

1
Mathematical comparison of protocols for adapting a bacteriophage to a new host.使噬菌体适应新宿主的方案的数学比较
Virus Evol. 2024 Nov 22;10(1):veae100. doi: 10.1093/ve/veae100. eCollection 2024.
2
Phage steering of antibiotic-resistance evolution in the bacterial pathogen, .噬菌体对细菌病原体抗生素耐药性进化的引导 , 。(你提供的原文似乎不完整)
Evol Med Public Health. 2020 Jul 11;2020(1):148-157. doi: 10.1093/emph/eoaa026. eCollection 2020.
3
Bacteriophage P22 SieA-mediated superinfection exclusion.噬菌体 P22 SieA 介导的超级感染排斥。
mBio. 2024 Feb 14;15(2):e0216923. doi: 10.1128/mbio.02169-23. Epub 2024 Jan 18.
4
Staphylococcus aureus Prophage-Encoded Protein Causes Abortive Infection and Provides Population Immunity against Kayviruses.金黄色葡萄球菌噬菌体编码蛋白导致流产感染,并为人群提供对凯弗病毒的免疫。
mBio. 2023 Apr 25;14(2):e0249022. doi: 10.1128/mbio.02490-22. Epub 2023 Feb 13.
5
Species-Scale Genomic Analysis of Staphylococcus aureus Genes Influencing Phage Host Range and Their Relationships to Virulence and Antibiotic Resistance Genes.金黄色葡萄球菌影响噬菌体宿主范围的基因的种属范围基因组分析及其与毒力和抗生素耐药基因的关系。
mSystems. 2022 Feb 22;7(1):e0108321. doi: 10.1128/msystems.01083-21. Epub 2022 Jan 18.
6
Experimental Evolution of the TolC-Receptor Phage U136B Functionally Identifies a Tail Fiber Protein Involved in Adsorption through Strong Parallel Adaptation.通过功能鉴定 TolC 受体噬菌体 U136B 的实验进化,确定了一种与吸附作用相关的尾丝蛋白,这是通过强烈的平行适应实现的。
Appl Environ Microbiol. 2023 Jun 28;89(6):e0007923. doi: 10.1128/aem.00079-23. Epub 2023 May 16.
7
Temperate phage-antibiotic synergy is widespread-extending to -but varies by phage, host strain, and antibiotic pairing.温和噬菌体与抗生素的协同作用广泛存在,适用于多种情况,但会因噬菌体、宿主菌株和抗生素组合的不同而有所差异。
mBio. 2025 Feb 5;16(2):e0255924. doi: 10.1128/mbio.02559-24. Epub 2024 Dec 20.
8
Genes Influencing Phage Host Range in Staphylococcus aureus on a Species-Wide Scale.在全物种范围内影响金黄色葡萄球菌噬菌体宿主范围的基因。
mSphere. 2021 Jan 13;6(1):e01263-20. doi: 10.1128/mSphere.01263-20.
9
Temperate phage-antibiotic synergy across antibiotic classes reveals new mechanism for preventing lysogeny.在不同抗生素类别中观察到温和噬菌体-抗生素协同作用,揭示了预防溶原性的新机制。
mBio. 2024 Jun 12;15(6):e0050424. doi: 10.1128/mbio.00504-24. Epub 2024 May 17.
10
Promises and Pitfalls of In Vivo Evolution to Improve Phage Therapy.体内进化改良噬菌体治疗的前景与挑战
Viruses. 2019 Nov 21;11(12):1083. doi: 10.3390/v11121083.

本文引用的文献

1
Personalized bacteriophage therapy outcomes for 100 consecutive cases: a multicentre, multinational, retrospective observational study.100 例连续病例的个体化噬菌体治疗结果:一项多中心、多国、回顾性观察研究。
Nat Microbiol. 2024 Jun;9(6):1434-1453. doi: 10.1038/s41564-024-01705-x. Epub 2024 Jun 4.
2
Controlling Recombination to Evolve Bacteriophages.控制重组以进化噬菌体。
Cells. 2024 Mar 28;13(7):585. doi: 10.3390/cells13070585.
3
The contribution of abortive infection to preventing populations of Lactococcus lactis from succumbing to infections with bacteriophage.
流产感染对防止乳球菌属(Lactococcus lactis)种群被噬菌体感染的贡献。
PLoS One. 2024 Apr 1;19(4):e0298680. doi: 10.1371/journal.pone.0298680. eCollection 2024.
4
Appelmans protocol - A directed in vitro evolution enables induction and recombination of prophages with expanded host range.Appelmans 方案——一种定向体外进化可诱导和重组具有扩大宿主范围的噬菌体。
Virus Res. 2024 Jan 2;339:199272. doi: 10.1016/j.virusres.2023.199272. Epub 2023 Nov 30.
5
Evolution to Increase the Titers of Difficult Bacteriophages: RAMP-UP Protocol.提高难培养噬菌体滴度的进化方法:加速方案
Phage (New Rochelle). 2023 Jun 1;4(2):68-81. doi: 10.1089/phage.2023.0005. Epub 2023 Jun 19.
6
Phage Therapy for Nontuberculous Mycobacteria: Challenges and Opportunities.非结核分枝杆菌的噬菌体疗法:挑战与机遇
Pulm Ther. 2023 Mar;9(1):91-107. doi: 10.1007/s41030-022-00210-y. Epub 2022 Dec 30.
7
Modeling the Directed Evolution of Broad Host Range Phages.模拟广宿主范围噬菌体的定向进化
Antibiotics (Basel). 2022 Nov 27;11(12):1709. doi: 10.3390/antibiotics11121709.
8
Phage Therapy of Mycobacterium Infections: Compassionate Use of Phages in 20 Patients With Drug-Resistant Mycobacterial Disease.噬菌体治疗分枝杆菌感染:20 例耐药分枝杆菌病患者中噬菌体的同情使用。
Clin Infect Dis. 2023 Jan 6;76(1):103-112. doi: 10.1093/cid/ciac453.
9
Computational Prediction of Bacteriophage Host Ranges.噬菌体宿主范围的计算预测
Microorganisms. 2022 Jan 12;10(1):149. doi: 10.3390/microorganisms10010149.
10
Potent antibody-mediated neutralization limits bacteriophage treatment of a pulmonary Mycobacterium abscessus infection.强效抗体介导的中和作用限制了噬菌体治疗肺部脓肿分枝杆菌感染。
Nat Med. 2021 Aug;27(8):1357-1361. doi: 10.1038/s41591-021-01403-9. Epub 2021 Jul 8.